The Scientist - Home

The University of California, Santa Barbara, cell biologist is investigating the formation and functions of the peroxisome, an organelle which exists in many copies in each cell and can be created, lost, or altered to meet the cell’s metabolic needs.

Preliminary data suggest that the newly dubbed Omicron variant may be more infectious than previous versions of the virus, but it will take time to obtain the reliable data needed to answer pressing questions about its biology.

The mitochondria stolen via these tiny connections give tumor cells a metabolic boost while the T cells are left weakened, according to in vitro experiments.

Genomic analysis of ancient chum salmon bones and cultural knowledge from the Tsleil-Waututh Nation suggest that people in the Pacific Northwest managed fisheries for thousands of years by harvesting males and releasing females.

The binding of histamine with one of its receptors within the tumor environment makes cancer cells more resistant to immunotherapy, according to a new study. Blocking that binding could improve responses to treatment.

Health Canada has given the single COVID-19 shot the official greenlight for use in people 18 and older.

The first chromosome-level genome assembly for a ctenophore may allow scientists to finally resolve the roots of the animal family tree.

The Scientist interviewed clinical pharmacologist Clara Locher, coauthor of a new survey aimed at detecting editorial bias, regarding her team’s findings about biomedical publishing.

The Scientist spoke with University of Wollongong ecologist Dana Bergstrom about protecting the continent’s native plants and animals in the face of climate change and a growing human presence.

The Howard Hughes Medical Institute will invest the funds over 10 years across all stages of the STEM pipeline.

A study finds that the odorless compound hexadecanal, or HEX, increases aggressive behavior in women but has a calming effect on men.

Tracking human cancers in mice shows some unexpected cell changes that could undermine translational research.